HCAT (Health Catalyst) LT-Debt-to-Total-Asset: 0.40 (As of Mar. 2026)

What is Health Catalyst LT-Debt-to-Total-Asset?

Health Catalyst HCAT +7.04% 44 LT-Debt-to-Total-Asset is 0.40 as of Mar. 2026. GuruFocus rates HCAT with a GF Score™ of 44/100 and a GF Value™ of $5.06 (Possible Value Trap). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Health Catalyst's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.40.

Health Catalyst's long-term debt to total assets ratio increased from Mar. 2025 (0.19) to Mar. 2026 (0.40). It may suggest that Health Catalyst is progressively becoming more dependent on debt to grow their business.

Health Catalyst (NAS:HCAT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Health Catalyst LT-Debt-to-Total-Asset Related Terms

Health Catalyst LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Health Catalyst's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Catalyst LT-Debt-to-Total-Asset Chart

Health Catalyst Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.24

0.33

0.35

0.20

0.33

Health Catalyst Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.19	0.27	0.28	0.33	0.40

44GF Score

Health Catalyst Inc HCAT

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Health Catalyst LT-Debt-to-Total-Asset Calculation

Health Catalyst's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	165.832	/	502.643
	=	0.33

Health Catalyst's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	165.22	/	412.202
	=	0.40

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.40 mean?

Health Catalyst (HCAT) has a LT-Debt-to-Total-Asset of 0.40 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Health Catalyst and its competitors.

Is Health Catalyst's LT-Debt-to-Total-Asset too high?

Health Catalyst's current LT-Debt-to-Total-Asset is 0.40. Overall, Health Catalyst has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Health Catalyst's LT-Debt-to-Total-Asset compare to CCLD and DH?

Health Catalyst's LT-Debt-to-Total-Asset of 0.40 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Health Catalyst and its competitors. Health Catalyst's current LT-Debt-to-Total-Asset is 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Health Catalyst stock overvalued right now?

Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.06, compared to a current price of $1.90 — trading 62.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.40. Health Catalyst's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Health Catalyst (HCAT), the current LT-Debt-to-Total-Asset is 0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $1.90 is trading 62.5% below its estimated GF Value™ of $5.06. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

LT-Debt-to-Total-Asset: 0.40
GF Value™: $5.06 vs. price of $1.90 (62.5% below fair value)
GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Health Catalyst Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies CCLD DH OPRX DRIO BEAT ONMD AMWL VASO CRVW BFRG VEEV BTSG ASX:PME TEM HQY TSE:2413 HKSE:02228 HNGE DOCS WAY

Other Exchanges 2YP:Germany

Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095

Website https://www.healthcatalyst.com

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

44GF Score

Get the complete analysis for HCAT

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90

Price

$5.06

GF Value

View HCAT Analysis

See LT-Debt-to-Total-Asset data for all stocks →